World's Best Scientists 2026 revealed!
Josep M. Campistol

Josep M. Campistol

D-Index & Metrics

Medicine

D-Index
89
Citations
36169
World Ranking
12517
National Ranking
175

Josep M. Campistol publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Josep M. Campistol sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 506 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Josep M. Campistol D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Josep M. Campistol sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Josep M. Campistol is affiliated with the University of Barcelona in Spain and has contributed extensively to research within medicine, particularly focusing on transplantation and related clinical studies. Their body of work reflects interdisciplinary expertise in fields such as medicine, biochemistry, genetics, and molecular biology.

Their research spans several main fields, including:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Campistol's subfields of study highlight an emphasis on applied medical and biological topics relevant to transplantation and disease, including:

  • Molecular Biology
  • Surgery
  • Transplantation
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Their research covers multiple specialized topics centering around organ transplantation and kidney-related conditions:

  • Renal Transplantation Outcomes and Treatments
  • Organ Transplantation Techniques and Outcomes
  • Organ Donation and Transplantation
  • COVID-19 Clinical Research Studies
  • Renal and related cancers
  • Pregnancy and preeclampsia studies
  • Renal Diseases and Glomerulopathies

Frequent coauthors collaborating with Campistol include:

  • Fritz Diekmann
  • Pedro Ventura-Aguiar
  • María José Ramírez-Bajo
  • Elisenda Bañón-Maneus
  • Ignacio Revuelta

Regular publication venues for their work feature journals with a strong focus on transplantation and rare diseases, such as:

  • American Journal of Transplantation
  • Transplantation
  • Transplant International
  • Orphanet Journal of Rare Diseases
  • Scientific Reports

Notable recent papers authored by or associated with Campistol include:

  • Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? (2020, American Journal of Transplantation)
  • PKU dietary handbook to accompany PKU guidelines (2020, Orphanet Journal of Rare Diseases)
  • A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells (2022, Cell Metabolism)
  • In vivo partial cellular reprogramming enhances liver plasticity and regeneration (2022, Cell Reports)
  • Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single center cohort of kidney recipients (2020, American Journal of Transplantation)

Best Publications

  • Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

    David Adams;Alejandra Gonzalez-Duarte;William D. O'Riordan;Chih Chao Yang

  • Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group.

    Carl G. Groth;Lars Bäckman;José-Maria Morales;Roy Calne

  • In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration

    Keiichiro Suzuki;Yuji Tsunekawa;Reyna Hernández-Benítez;Reyna Hernández-Benítez;Jun Wu;Jun Wu

  • Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

    Merrill D. Benson;Márcia Waddington-Cruz;John L. Berk;Michael Polydefkis

  • Tafamidis for transthyretin familial amyloid polyneuropathy A randomized, controlled trial

    Teresa Coelho;Luis F. Maia;Ana Martins da Silva;Marcia Waddington Cruz

  • High-Efficiency Postdilution Online Hemodiafiltration Reduces All-Cause Mortality in Hemodialysis Patients

    Francisco Maduell;Francesc Moreso;Mercedes Pons;Rosa Ramos

  • In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming

    Alejandro Ocampo;Pradeep Reddy;Paloma Martinez-Redondo;Aida Platero-Luengo

  • Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.

    F. Vincenti;S. Friman;E. Scheuermann;L. Rostaing

  • Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.

    Henri Kreis;Jean-Marc Cisterne;Walter Land;Lars Wramner

  • Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.

    Francesco P. Schena;Michael D. Pascoe;Josefina Alberu;Maria del Carmen Rial

  • Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation

    Sylvie Euvrard;Emmanuel Morelon;Emmanuel Morelon;Lionel Rostaing;Eric Goffin

  • A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)

    A. Durrbach;J. M. Pestana;T. Pearson;F. Vincenti

  • Sirolimus Therapy after Early Cyclosporine Withdrawal Reduces the Risk for Cancer in Adult Renal Transplantation

    Josep M. Campistol;Josette Eris;Rainer Oberbauer;Peter Friend

  • Interspecies Chimerism with Mammalian Pluripotent Stem Cells

    Jun Wu;Aida Platero-Luengo;Masahiro Sakurai;Atsushi Sugawara

  • Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.

    Alex Gutierrez-Dalmau;Josep M Campistol

  • In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation.

    Hsin-Kai Liao;Fumiyuki Hatanaka;Toshikazu Araoka;Toshikazu Araoka;Pradeep Reddy

  • SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION

    Carl G. Groth;Maria Morales;Roy Calne;Henri Kreis

  • Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells.

    Yun Xia;Emmanuel Nivet;Ignacio Sancho-Martinez;Thomas Gallegos

  • Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study

    Ole B Suhr;Teresa Coelho;Juan Buades;Jean Pouget

  • Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma.

    Josep M. Campistol;Alex Gutierrez-Dalmau;J. Vicente Torregrosa

Frequent Co-Authors

Josep M. Grinyó
Josep M. Grinyó University of Barcelona
David H. Adams
David H. Adams Mount Sinai Hospital
Concepcion Rodriguez Esteban
Concepcion Rodriguez Esteban Salk Institute for Biological Studies
Jun Wu
Jun Wu The University of Texas Southwestern Medical Center
Christophe Legendre
Christophe Legendre Necker-Enfants Malades Hospital
Henri Kreis
Henri Kreis Necker-Enfants Malades Hospital
Jordi Rello
Jordi Rello Instituto de Salud Carlos III
Giampaolo Merlini
Giampaolo Merlini University of Pavia
Peter J. Dyck
Peter J. Dyck Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens up many related online degree options and alternative pathways in the healthcare field. For those interested in mental health, online pmhnp programs can fast-track your journey to becoming a Psychiatric Mental Health Nurse Practitioner. These programs often offer flexibility for working professionals or those balancing other commitments.

Students focused on the business side of healthcare may want to consider healthcare administration degrees. These online degrees help develop essential skills for leadership positions in hospitals, clinics, and healthcare organizations, covering topics such as policy, finance, and operations.

Affordability is a key concern for many prospective students. Fortunately, there are cheapest mha programs online healthcare that provide rigorous graduate training at a lower cost, making them accessible to a wider range of learners.

For advanced nursing leadership and clinical roles, students can pursue cheap online dnp programs to earn a Doctor of Nursing Practice. These programs focus on clinical expertise, healthcare innovation, and improved patient outcomes, while offering online convenience.

Best Scientists Citing Josep M. Campistol

Trending Scientists

Recently Published Articles